Table 3.
- Relationship between anticoagulant type and the effectiveness of prothrombin complex concentrate and the dose.
Types of anticoagulants | Effective n (%) (M±SD) | Ineffective n (%) (M±SD) | Total (n,%) | P-value | |
---|---|---|---|---|---|
VKA PCC dose | 14 (88) 2196±573.3 |
2 (12) 1000±707.1 |
16 (100) | 0.02 | |
Dabigatran PCC dose | 1 (50) 2000 |
1 (50) 2500 |
2 (100) | ||
Rivaroxaban PCC dose | 4 (100) 2156±986.2 |
0 | 4 (100) | ||
PCC: prothrombin complex concentrate |